T-cell receptor
From Proteopedia
(Difference between revisions)
(24 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | + | <StructureSection load='' size='350' side='right' scene='53/536684/Cv/1' caption='T-cell receptor α chain (deepskyblue), β chain (green) complex with enterotoxin (pink), glycerol and Na+ ion (purple) [[2xna]].'> | |
- | '''T-cell receptors''' (TCR) reside on the surface of T lymphocytes. TCR recognizes antigens bound to major histocompatibility complex (MHC) molecules. The binding of TCR to the antigen-MHC activates the T lymphocytes. TCR is a heterodimer α+β and ca. 5% the T cells have | + | __TOC__ |
+ | == Function == | ||
+ | '''T-cell receptors''' (TCR) reside on the surface of T lymphocytes. TCR recognizes antigens bound to major histocompatibility complex (MHC) molecules. The binding of TCR to the antigen-MHC activates the T lymphocytes<ref>PMID:17624994</ref>. TCR is a heterodimer of '''α+β subunits''' and ca. 5% the T cells have '''γ+δ subumits'''. '''TCR NKT''' reside in Natural Killer T-cells. | ||
+ | *<scene name='53/536684/Cv/3'>T-cell receptor α chain, β chain complex with enterotoxin and Na+ ion</scene> ([[2xna]]). | ||
+ | For more details see [[SP3.4-TCR-HLA-DQ8-∝-1-gliadin_complex]]. | ||
+ | |||
+ | == Relevance == | ||
+ | Genes encoding antigen-specific receptors into T cells can redirect their functional activity against targets including virally infected or cancer cells<ref>PMID:22610778</ref>. This technique is currently developed by several biotechnology companies and implemented in therapy. | ||
== 3D structures of T-cell receptor== | == 3D structures of T-cell receptor== | ||
+ | [[T-cell receptor 3D structures]] | ||
- | + | </StructureSection> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | == References == | |
- | + | <references/> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
|
References
- ↑ Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF, Nagy LE. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res. 2007 Sep;31(9):1581-8. Epub 2007 Jul 11. PMID:17624994 doi:http://dx.doi.org/10.1111/j.1530-0277.2007.00452.x
- ↑ Uttenthal BJ, Chua I, Morris EC, Stauss HJ. Challenges in T cell receptor gene therapy. J Gene Med. 2012 Jun;14(6):386-99. doi: 10.1002/jgm.2637. PMID:22610778 doi:http://dx.doi.org/10.1002/jgm.2637
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky